canonical: https://aviantestpro.com/knowledge/disease-testing/pigeon-disease-panel
Pigeon Disease Panel (11 Pathogens)¶
Overview¶
SENO's comprehensive pigeon disease panel detects 11 clinically relevant pathogens from a single sample collection using validated PCR and RT-PCR assays. The panel is designed to provide complete health screening for racing pigeons, breeding stock, and quarantine populations, enabling early detection and targeted treatment before clinical outbreaks occur.
Why Screen for 11 Pathogens?¶
Respiratory, digestive, and neurological signs in pigeons are frequently caused by overlapping pathogens. Testing each pathogen individually is expensive and delays diagnosis. SENO's 11-pathogen panel provides complete coverage in a single submission:
- Viral: 5 pathogens (PiHV, PiCV, PiADV, PPMV-1, NDV)
- Bacterial: 4 pathogens (Salmonella, E. coli, Chlamydia psittaci, Mycoplasma spp.)
- Viral (OIE notifiable): Avian Influenza Virus (AIV)
- Fungal: Candida albicans
Panel Composition — Pathogen-by-Pathogen Detail¶
| # | Pathogen | Type | Genome | Detection Method | Clinical Signs | Treatment Implications | Sample Type |
|---|---|---|---|---|---|---|---|
| 1 | Pigeon Herpes Virus (PiHV) | DNA virus | dsDNA | PCR | Respiratory distress, conjunctivitis, hepatic necrosis, neurological signs, yellow plaques in pharynx | Supportive care; acyclovir may reduce shedding; no cure for latent infection | Oropharyngeal swab |
| 2 | Pigeon Circovirus (PiCV) | DNA virus | ssDNA | PCR | Immunosuppression, young bird disease (6–12 weeks), secondary infections, poor performance | No specific antiviral; manage secondary infections; improve loft hygiene | Cloacal swab |
| 3 | Pigeon Adenovirus (PiADV) | DNA virus | dsDNA | PCR | Hepatic necrosis, enteritis ("young bird sickness"), vomiting, green diarrhea, rapid weight loss | Supportive care (fluids, electrolytes); antibiotics for secondary infections | Cloacal swab / feces |
| 4 | Pigeon Paramyxovirus-1 (PPMV-1) | RNA virus | ssRNA(−) | RT-PCR | Neurological signs (torticollis, tremors, paralysis), green diarrhea, polydipsia, sudden death | No treatment; vaccination available; OIE-notifiable in some regions | Oropharyngeal + cloacal swab |
| 5 | Newcastle Disease Virus (NDV) | RNA virus | ssRNA(−) | RT-PCR | Respiratory distress, neurological signs, drop in egg production, conjunctivitis | No treatment; OIE-notifiable; vaccination control | Oropharyngeal + cloacal swab |
| 6 | Avian Influenza Virus (AIV) | RNA virus | ssRNA(−) | RT-PCR | Respiratory signs, cyanosis, edema, drop in performance, sudden death in highly pathogenic strains | No treatment; OIE-notifiable; depopulation protocol may apply | Oropharyngeal + cloacal swab |
| 7 | Salmonella enterica | Bacteria | DNA | PCR | Enteritis, septicemia, arthritis ("bumblefoot"), torticollis (cerebral form), poor racing form, swollen joints | Antibiotic sensitivity recommended; enrofloxacin, amoxicillin; culling of chronic carriers | Cloacal swab / feces |
| 8 | Escherichia coli (pathogenic) | Bacteria | DNA | PCR | Enteritis, colisepticemia, respiratory signs, egg peritonitis in breeders, poor growth in young birds | Antibiotic sensitivity recommended; treatment with trimethoprim-sulfa or amoxicillin | Cloacal swab / feces |
| 9 | Chlamydia psittaci | Bacteria (obligate intracellular) | DNA | PCR | Respiratory distress, conjunctivitis, mucopurulent discharge, green droppings, lethargy — ZOONOTIC | Doxycycline 45 days minimum; isolate from humans during treatment; OIE-notifiable | Oropharyngeal swab |
| 10 | Mycoplasma spp. | Bacteria (wall-less) | DNA | PCR | Respiratory signs, airsacculitis, nasal discharge, conjunctivitis, reduced racing performance | Tylosin, tiamulin, doxycycline; slow-growing, treatment may be prolonged | Oropharyngeal swab |
| 11 | Candida albicans | Fungus (yeast) | DNA | PCR | Crop mycosis ("candidiasis"), white plaques in mouth, regurgitation, slow crop emptying, digestive disturbance | Nystatin (oral), fluconazole; correct underlying causes (poor diet, immunosuppression) | Oral swab |
Sample Requirements¶
| Sample Type | Quantity | Collection Method | Storage | Stability |
|---|---|---|---|---|
| Oropharyngeal swab | 1 swab | Swab both oropharynx and choanal slit | Nucleic acid stabilization solution | 7 days at room temp; 30 days at 4°C |
| Cloacal swab | 1 swab | Insert 1 cm, rotate gently | Nucleic acid stabilization solution | 7 days at room temp; 30 days at 4°C |
| Fresh feces | 0.5–1.0 g | Collect from clean surface (not litter) | Sterile container, refrigerated | 48 h at 4°C; freeze at −20°C for longer |
| Combined swab | 1 swab | Oropharyngeal + cloacal on one swab | Nucleic acid stabilization solution | Acceptable for most targets except Chlamydia |
Minimum Submission Options¶
| Scenario | Recommended Collection | Reason |
|---|---|---|
| Standard health screen | 1 oropharyngeal + 1 cloacal swab | Covers all 11 pathogens |
| Respiratory signs only | 1 oropharyngeal swab | Catches PiHV, Chlamydia, Mycoplasma, AIV, NDV, PPMV-1 |
| Digestive signs only | 1 cloacal swab or fresh feces | Catches PiADV, Salmonella, E. coli, Candida |
| Neurological signs | 1 oropharyngeal + 1 cloacal swab | Must cover PPMV-1, NDV, Salmonella |
| Zoonotic risk assessment | 1 oropharyngeal swab | Chlamydia psittaci testing priority |
| Post-mortem | Liver, spleen, lung, brain tissue (separate containers) | Most sensitive for all targets |
When to Test¶
| Scenario | Timing | Panel Priority |
|---|---|---|
| Pre-season health check | 4–6 weeks before racing season | Full panel — identify carriers before stress of competition |
| New bird introduction | Day 1 of quarantine | Full panel prevents introduction of novel pathogens |
| Performance decline | Immediately | Unexplained drop in racing results — often subclinical infection |
| Clinical signs | Immediately upon observation | Targeted or full panel depending on signs |
| Post-event screening | Within 1 week after exposure | After one-loft races, shows, or sales events |
| Breeding stock clearance | 4 weeks before pairing | Full panel — vertical transmission risk (PiADV, Chlamydia) |
| Mortality investigation | Within 24 h of death | Post-mortem tissue panel |
Result Format¶
Results are reported per pathogen as:
| Result | Meaning | Recommendation |
|---|---|---|
| Positive | Pathogen DNA/RNA detected | Ct value and semi-quantitative interpretation provided; consult treatment table above |
| Negative | Not detected | No evidence of current infection; continue routine biosecurity |
| Invalid | Internal control failure | Sample may contain inhibitors; re-collection recommended |
| Low Positive | Ct > 35, borderline | Retest with fresh sample within 2 weeks to confirm |
Co-Infection Patterns¶
Pigeons frequently carry multiple pathogens simultaneously. Recognizing common co-infection patterns helps prioritize treatment and identify underlying management issues.
| Common Co-Infection | Associated Clinical Picture | Prevalence in Sick Birds | Management Implication |
|---|---|---|---|
| PiCV + PiADV | Classic "young bird sickness" — immunosuppression precedes adenovirus enteritis | 25–35% | Treat PiADV symptoms; improve loft hygiene to reduce PiCV transmission |
| PiHV + Chlamydia psittaci | Severe respiratory disease with conjunctivitis; exacerbated by stress | 15–20% | Dual antibiotic course (doxycycline + supportive); separate airspace |
| PPMV-1 + Salmonella | Neurologic signs + enteritis; often mistaken for single pathogen | 10–15% | Newcastle vaccination history critical; antibiotic sensitivity for Salmonella |
| Mycoplasma + E. coli | Chronic respiratory disease with secondary bacterial infection | 20–25% | Tylosin or tiamulin for Mycoplasma; antibiotics selected by sensitivity |
| Candida + any immunosuppressive (PiCV, PBFD) | Secondary fungal infection following immunosuppression | 8–12% | Treat underlying cause; nystatin or fluconazole; improve nutrition |
| Triple infection (PiCV + PiADV + Candida) | Common in young birds (6–16 weeks) from poorly managed lofts | 5–10% | Full supportive care; requires environmental correction |
Seasonal Prevalence Trends¶
| Pathogen | Peak Season | Notes |
|---|---|---|
| PiHV | Spring + Autumn | Reactivates under stress (breeding, racing transport, moulting) |
| PiCV | Summer (young bird season) | Most prevalent in squabs and young birds 6–12 weeks old |
| PiADV | Summer — Autumn | Tracks with young bird racing season |
| PPMV-1 | Autumn — Winter | Seasonal pattern influenced by outdoor temperature and bird congregation |
| Chlamydia psittaci | All year (endemic in some lofts) | Peaks in spring (breeding) and autumn (migration/racing) |
| Salmonella | Summer | Warm, humid conditions favour environmental persistence |
| Mycoplasma | All year | Chronic carrier birds shed continuously; stress triggers outbreaks |
| Candida | Summer | Warm, damp loft conditions favour fungal overgrowth |
Loft Biosecurity Recommendations by Pathogen¶
| Pathogen | Biosecurity Measure | Disinfectant Effective Against | Carrier Management |
|---|---|---|---|
| PiHV | Dedicated perches, no shared water sources | 10% bleach, 2% Virkon S, accelerated H₂O₂ | Test all new birds; isolate suspected carriers |
| PiCV | Shoe baths at loft entry; age-segregated housing | 10% bleach, 2% Virkon S | Remove persistently positive birds from breeding |
| PiADV | Limit young bird crowding; avoid shared feeding trays | 10% bleach, 70% ethanol | Quarantine affected age group |
| PPMV-1 | Vaccination program mandatory; quarantine new arrivals | 2% Virkon S, phenolic compounds | Cull unvaccinated positives; report to authorities |
| NDV | Biosecurity + vaccination; restrict visitor access | Phenolic disinfectants, accelerated H₂O₂ | OIE-notifiable — mandatory reporting |
| AIV | Wild bird contact prevention; netted lofts | Accelerated H₂O₂, phenolic compounds | OIE-notifiable — mandatory reporting |
| Salmonella | Rodent control; no ground feeding; foot baths | 10% bleach, 2% Virkon S | Antibiotic sensitivity required; cull chronic carriers |
| E. coli | Clean feeding surfaces; no spoiled grain | 10% bleach, quaternary ammonium | Improve loft hygiene; sensitivity-guided treatment |
| Chlamydia psittaci | Respiratory protection (N95) for handlers; dedicated equipment | 2% Virkon S, 70% ethanol (10 min contact) | Zoonotic — test all suspect birds |
| Mycoplasma | Minimize dust and ammonia; good ventilation | Quaternary ammonium compounds | Improve loft ventilation; treat entire flock |
| Candida | Clean feeders daily; no moldy grain; dry loft conditions | 10% bleach, antifungal fogging | Correct husbandry; treat affected birds |
OIE Notifiable Pathogens — Reporting Obligations¶
| Pathogen | OIE Notification Required | Regional Variations |
|---|---|---|
| Avian Influenza Virus (AIV) | Yes — HPAI strains (H5, H7) | All WOAH member countries |
| Newcastle Disease Virus (NDV) | Yes — velogenic strains | All WOAH member countries |
| Chlamydia psittaci | Depends on jurisdiction | Notifiable in EU (many member states), some US states, China |
| PPMV-1 | Depends on jurisdiction | Notifiable in EU (variant of NDV); not always notifiable outside EU |
| Salmonella enterica (specific serovars) | Some serovars notifiable | S. Pullorum, S. Gallinarum in poultry; racing pigeons generally exempt |
Testing Methodology¶
The 11-pathogen panel uses a combination of singleplex and multiplex PCR/RT-PCR reactions:
| Reaction | Targets | Chemistry | Rationale |
|---|---|---|---|
| Multiplex 1 | PiHV + PiCV | Duplex PCR (two primer pairs) | Both DNA viruses; compatible annealing temperatures |
| Multiplex 2 | PiADV + internal control | Duplex PCR | Ensure sample adequacy with IC |
| Multiplex 3 | PPMV-1 + NDV + AIV | Triplex RT-PCR | All RNA viruses requiring RT step |
| Multiplex 4 | Salmonella + E. coli | Duplex PCR | Both Gram-negative enteric bacteria |
| Singles | Chlamydia psittaci + Mycoplasma spp. + Candida albicans | Individual PCR reactions | Required for optimal sensitivity with these fastidious/chronic pathogens |
Each reaction includes: - Positive control — synthetic target DNA/RNA or cultured organism - Negative control — nuclease-free water - Internal control — spiked into samples to detect inhibition
Cross-References¶
- PBFD / BFDV Testing — Individual BFDV qPCR assay
- Performance Gene Testing — Genetic screening for racing potential
- DNA Extraction SOP — Sample preparation methodology
- PCR Troubleshooting — Resolving amplification issues
- International Shipping Guide — Submitting samples globally
This document is maintained by SENO's R&D and Veterinary Advisory teams. For clinical inquiries, contact [email protected].